Search for Clinical Trial Results

Sponsored By

Diffuse Cutaneous Systemic Sclerosis - 23 Studies Found

Status Study
Completed Study Name: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma
Condition:
  • Limited Scleroderma
  • Diffuse Scleroderma

Date: 2013-06-05
Terminated Study Name: Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
Condition: Scleroderma, Systemic
Date: 2007-01-03
Interventions:
  • Drug: Thalidomide Thalidomide

Active, not recruiting Study Name: Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis
Condition: Scleroderma, Systemic
Date: 2014-11-03
Interventions:
  • Drug: Riociguat (Adempas, BAY63-2521)

<<< Previous